Current Fellow

Mohamed Shama, MD

Photo of Dr. Shama

Fellow

 

Contact

ENT Clinic at Shands at UF

  • Phone: (352) 265-8989
  • Fax: (352) 265-8968

ENT Call Center
Patient Appointments

  • Phone: (352) 265-0920
  • Fax: (352) 627-4411

Academic Office

  • Phone: (352) 273-5199
  • Fax: (352) 392-6781

Email

 


 

Education

  • FELLOWSHIP, Thyroid and Parathyroid Surgery
    Harvard Medical School Massachusetts Eye and Ear
    Boston, MA
    2016 – 2018
  • RESIDENCY, Surgical Oncology
    National Cancer Institute-Cairo
    Cairo, Eqypt
    2004 – 2007
  • MEDICAL SCHOOL, Master of General Surgery (MD)
    Cairo University
    Cairo, Egypt
    2011 – 2013
  • MEDICAL SCHOOL, Bachelor of Medicine, Bachelor of Surgery (MBBCH)
    Cairo University
    Cairo, Eqypt
    1995 – 2002

 

 

Certification

  • Educational Commission for Foreign Medical Graduates (2009)
  • European Board of Surgery Qualifications, Surgical Oncology (2014)

 

Academic Affiliations

  • Royal College of Surgeons of England
  • Egyptian Society of Head and Neck Oncology
  • Egyptian Society of Microvascular Surgery
  • Egyptian Society of Surgical Oncologists
  • Egyptian Medical Syndicate

 

 

Publications

  1. Minimal Extrathyroidal Extension does not affect Survival of Well-differentiated Thyroid Cancer.
    Mohamed A. Shama, Zaid Qurayshi, Gregory W. Randolph, Emad Kandil. Tulane University, LA –
    Massachusetts Eye and Ear/Harvard Medical School, MA, USA; Endocrine Related Cancer- 2017 May.
  2. Association of diabetes with perineural invasion in pancreatic cancer. Sahin IH, Shama MA, Tanaka M,
    Abbruzzese JL, Curley SA, Hassan M, Li D. ; The University of Texas M. D. Anderson Cancer Center,
    Houston, TX; Cancer Medicine – 2012 Dec.
  3. Treatment outcome and prognostic indicators in 94 cases of fibrolamellar hepatocellular carcinoma.
    Ahmed O Kaseb, Mohamed Shama, Ibrahim Halil Sahin, Ajay Nooka, Hesham M Hassabo, Jean-Nicolas
    Vauthey, Thomas Aloia, James L Abbruzzese, Ishwaria M Subbiah, Filip Janku, Steven Curley, Manal M
    Hassan. ; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Oncology- 2013
  4. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis
    prediction. Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama
    M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E,
    Soliman KM, Li D ; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Molecular
    Carcinogenesis – 2013 Jun.
  5. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular
    Carcinoma. Yamashita S, Vauthey JN, Kaseb AO, Aloia TA, Conrad C, Hassan MM, Passot G, Raghav KP,
    Shama MA, Chun YS; The University of Texas M. D. Anderson Cancer Center, Houston, TX; J Gastrointest
    Surg- 2016 Oct.

 

Presentations

  • ACS 2016 – Washington, USA.
     Mohamed Shama, Zaid Qurayshi, Emad Kandil. Tulane University, LA. Minimal Invasion, Nodal
    Metastasis, and Tumor Size Impact on Survival of Patients with Stage III Papillary Thyroid Cancer.
     Mohamed Shama, Zaid Qurayshi, Emad Kandil. Tulane University, LA. The Role and Associated
    Disparities in the Utilization of Radioiodine Therapy and Total Thyroidectomy in Patients with Low Risk
    Thyroid Cancer.
     Mohamed Shama, Zaid Qurayshi, Emad Kandil. Tulane University, LA. Total Thyroidectomy versus
    Lobectomy in Patient with Suspicious for Papillary Thyroid Cancer Nodule on Fine-Needle-Aspiration:
    Cost-Effectiveness Analysis.